<DOC>
	<DOCNO>NCT01278797</DOCNO>
	<brief_summary>This study open-label , randomize , two-treatment , two-period , two-sequence crossover study evaluate bioequivalence amlodipine component Boehringer Ingelheim Pharma GmbH &amp; Co. KGs 80 mg telmisartan/10 mg amlodipine fix dose combination tablet correspond mono-component amlodipine tablet , 10 mg ( Pfizers Norvasc ) .</brief_summary>
	<brief_title>Telmisartan Amlodipine Versus Monocomponent Tablets</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy , nonsmoking , male and/or postmenopausal/surgically sterile female subject 18 55 year age . 2 . Females participate study must either : 1. postmenopausal least 1 year ( menstrual cycle 12 consecutive month ) deem postmenopausal physician base screen clinical laboratory test ( Follicle stimulate hormone ( FSH ) Luteinising Hormone ( LH ) 2. provide proof surgical sterility . 3 . Body Mass Index ( BMI ) great equal 19.0 less equal 30.0 kg/m2 . 4 . No clinically significant finding vital sign measurement systolic blood pressure great equal 110 mmHg screening . 5 . No clinically significant abnormal laboratory value . 6 . No clinically significant finding 12lead electrocardiogram ( ECG ) time P R wave ECG ( PR interval ) less equal 200 m screening . 7 . Have significant disease . 8 . Be inform nature study give write consent prior receive study procedure . 9 . Have clinically significant finding physical examination . Exclusion criterion : 1 . Known history presence clinically significant medical condition . 2 . Known suspected carcinoma . 3 . History presence cardiovascular dysfunction ( e.g . increase angina , myocardial infarction , outflow obstruction , congestive heart failure ) . 4 . History clinically significant hypotension . 5 . Presence hepatic dysfunction . 6 . Known history presence galactose fructose intolerance , sucraseisomaltase insufficiency , Lapp lactase insufficiency , galactosemia , glucosegalactose malabsorption syndrome . 7 . History gastrointestinal tract surgery ( appendectomy permit ) . 8 . Presence clinically significant gastrointestinal disease history malabsorption within last year . 9 . Presence medical condition require regular medication ( prescription and/or overthecounter ) systemic absorption . 10 . History drug alcohol addiction require treatment . 11 . Positive test result serum hCG consistent pregnancy ( female ) , HIV , Hepatitis B surface antigen , Hepatitis C antibody . 12 . Positive test result urine drug abuse ( cannabinoids , opiate , amphetamine , cocaine , phencyclidine , tricyclic antidepressant , barbiturate , methadone , benzodiazepine ) urine cotinine . 13 . Difficulty fast consume standard meal . 14 . Females pregnant , lactating , likely become pregnant study . 15 . Does tolerate venipuncture . 16 . Use tobacco nicotinecontaining product within 6 month prior drug administration . 17 . On special diet within 30 day prior drug administration ( e.g . liquid , protein , raw food diet ) . 18 . Participated another clinical trial receive investigational product within 30 day prior drug administration . 19 . Donation loss whole blood : 1 . Great equal 50 mL less equal 499 mL within 30 day prior dose 2. great equal 500 mL within 56 day prior dose . 20 . Females use hormonal contraceptive within 6 month prior drug administration . 21 . Have tattoo body pierce within 30 day prior dose . 22 . Known history presence hypersensitivity idiosyncratic reaction telmisartan , amlodipine , drug substance similar activity . 23 . Use drug know : 1. induce ( e.g . barbiturate , carbamazepine , phenytoin , glucocorticoid , omeprazole ) 2. inhibit ( e.g . antidepressant ( Selective Seratonin Reuptake Inhibitor ( SSRI ) I ) , cimetidine , diltiazem , macrolides , imidazole , neuroleptic , verapamil , fluoroquinolones , antihistamine ) hepatic drug metabolism within 30 day prior drug administration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>